Quinazolinone Derivatives Useful as Vanilloid Antagonists
    1.
    发明申请
    Quinazolinone Derivatives Useful as Vanilloid Antagonists 有权
    喹唑啉酮衍生物作为香草素拮抗剂有用

    公开(公告)号:US20100197705A1

    公开(公告)日:2010-08-05

    申请号:US12683317

    申请日:2010-01-06

    CPC classification number: C07D239/91 A61K31/517

    Abstract: There is described a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile having structural formula I(B) and to a method of preparing it.There is further a process or method for the manufacture of a pharmaceutically active quinazolinone compounds of the formula I wherein the symbols have the meanings given in the description, said process comprising reacting a compound of the formula II, wherein R4* is R1*—C(═O)— wherein R1* is independently selected from the group of meanings of R1 as defined for a compound of the formula I so that R1* and R1 are identical to or different from each other, or R4* is especially H, and R1 and R3, R5 and R6 are as defined for a compound of the formula I, or a salt thereof, under simultaneous or sequential condensation and cyclisation conditions with an aniline compound of the formula III, wherein R2 and m are as defined for a compound of the formula I. Further reactions and related embodiments are also claimed and disclosed.

    Abstract translation: 描述了具有结构式I(B)的4-(7-羟基-2-异丙基-4-氧代-4H-喹唑啉-3-基) - 苄腈的新的多晶型物及其制备方法。 还有一种用于制备式I的药学活性喹唑啉酮化合物的方法或方法,其中符号具有在说明书中给出的含义,所述方法包括使式II化合物,其中R4 *是R1 * -C (ΟO) - 其中R 1 *独立地选自如式I化合物所定义的R 1的含义,使得R 1 *和R 1彼此相同或不同,或者R 4 *特别是H,和 R 1和R 3,R 5和R 6如式I化合物或其盐在同时或连续的缩合和环化条件下与式III的苯胺化合物所定义,其中R 2和m如化合物 其他反应和相关实施方案也被要求保护和公开。

Patent Agency Ranking